Colestilan monotherapy significantly improves glycaemic control and LDL cholesterol levels in patients with type 2 diabetes: a randomized double-blind placebo-controlled study (Q43202797)
Jump to navigation
Jump to search
scientific article published on 22 September 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Colestilan monotherapy significantly improves glycaemic control and LDL cholesterol levels in patients with type 2 diabetes: a randomized double-blind placebo-controlled study |
scientific article published on 22 September 2009 |
Statements
1 reference
Colestilan monotherapy significantly improves glycaemic control and LDL cholesterol levels in patients with type 2 diabetes: a randomized double-blind placebo-controlled study (English)
1 reference
K Kondo
1 reference
T Kadowaki
1 reference
22 September 2009
1 reference
1 reference
1 reference
Identifiers
1 reference